BRIEF published on 06/02/2026 at 14:35, 18 hours 1 minute ago Inventiva Resumes Trading on Euronext Paris Euronext Paris Debt Financing Trading Resumption Inventiva MASH Treatment
PRESS RELEASE published on 06/02/2026 at 14:30, 18 hours 6 minutes ago Inventiva Announces Trading Resumption of its Ordinary Shares on Euronext Paris Inventiva announces trading resumption of its ordinary shares on Euronext Paris following Debt Financing Transaction and ADS Offering Euronext Paris Ordinary Shares Clinical-Stage Biopharmaceutical Trading Resumption Inventiva
BRIEF published on 06/02/2026 at 07:35, 1 day 1 hour ago Temporary suspension of Inventiva shares on Euronext Paris Euronext Paris Funding Nasdaq Inventiva Temporary Suspension
BRIEF published on 06/02/2026 at 07:35, 1 day 1 hour ago Inventiva Halts Trading of Ordinary Shares on Euronext Paris Euronext Paris Trading Halt Inventiva MASH Treatment Nadsaq
PRESS RELEASE published on 06/02/2026 at 07:30, 1 day 1 hour ago Inventiva Announces Temporary Trading Halt of its Ordinary Shares on Euronext Paris Inventiva announces temporary trading halt of its ordinary shares on Euronext Paris for a proposed financing transaction. Trading to resume after communication Euronext Paris Trading Halt Clinical Trial Inventiva Metabolic Dysfunction
BRIEF published on 05/26/2026 at 22:05, 7 days 10 hours ago Inventiva Announces its First Quarter 2026 Financial Results Financial Results Treasury Biopharmaceutical Inventiva NATiV3
PRESS RELEASE published on 05/26/2026 at 22:00, 7 days 10 hours ago Inventiva Reports 2026 First Quarter Financial Information¹ Inventiva reports first quarter 2026 financial information, with cash and cash equivalents at €75.0 million and short-term deposits at €121.5 million. Explore company's financial results and upcoming milestones Financial Information Inventiva NATiV3 Cash Equivalents Short-term Deposits
BRIEF published on 05/21/2026 at 22:05, 12 days 10 hours ago Inventiva at the 2026 Jefferies Global Healthcare Conference Biopharmaceutical Inventiva MASH Lanifibranor Jefferies Conference
BRIEF published on 05/21/2026 at 22:05, 12 days 10 hours ago Inventiva to Present at 2026 Jefferies Global Healthcare Conference Biopharmaceutical Inventiva Lanifibranor MASH Treatment Jefferies Conference
PRESS RELEASE published on 05/21/2026 at 22:00, 12 days 10 hours ago Inventiva to Present at 2026 Jefferies Global Healthcare Conference Inventiva to present at 2026 Jefferies Global Healthcare Conference in New York City. CEO Andrew Obenshain to speak on June 3, 2026, about MASH therapies Clinical-Stage Biopharmaceutical Inventiva Lanifibranor 2026 Jefferies Conference MASH Therapies
Published on 06/03/2026 at 04:58, 3 hours 38 minutes ago Snipp Interactive Reports Q1 2026 Financial Results; Bookings Backlog Reaches Record $20.6 Million; Announces Conference Call on Wednesday, June 3, 2026
Published on 06/03/2026 at 00:00, 8 hours 36 minutes ago Onco-Innovations Advances 1kg Scale-Up of B4 Precursor Supporting ONC010 Manufacturing and Clinical Development Program
Published on 06/02/2026 at 22:30, 10 hours 6 minutes ago INEO Announces Effective Date of Share Consolidation
Published on 06/02/2026 at 19:45, 12 hours 51 minutes ago Announces Plans to Repurchase Common Shares
Published on 06/03/2026 at 08:00, 36 minutes ago Aquis Stock Exchange: Application for Admission Announcement
Published on 06/03/2026 at 07:35, 1 hour 1 minute ago Factorial Raises $150M Series D, Reaches $2.5 Billion Valuation to Become One of the Most Valuable AI Scale-Ups in Europe
Published on 06/03/2026 at 07:30, 1 hour 6 minutes ago voestalpine AG: voestalpine increases earnings despite a volatile environment in the 2025/26 business year
Published on 06/03/2026 at 07:30, 1 hour 6 minutes ago Deutsche Rohstoff AG: 2026 development on track– first pad delivers strong initial production
Published on 06/03/2026 at 07:05, 1 hour 31 minutes ago National Bank of Georgia Launches Modernized RTGS Payment System with Montran
Published on 06/02/2026 at 18:03, 14 hours 33 minutes ago Total number of voting rights and shares making up the share capital at May 31, 2026
Published on 06/02/2026 at 17:42, 14 hours 54 minutes ago Aéroports de Paris SA - Shares and voting rights as of 31 May 2026
Published on 06/02/2026 at 17:40, 14 hours 56 minutes ago Campus AI enters the implementation phase: Eiffage selected for deployment of shared infrastructure on the Fouju Campus in a deal worth over €120 million
Published on 06/02/2026 at 08:00, 1 day ago EURAZEO’S PRIVATE DEBT FUND CLOSES AT RECORD €3.9 BILLION, EXCEEDING ITS INITIAL TARGET
Published on 06/02/2026 at 07:30, 1 day 1 hour ago OPmobility strengthens its U.S. footprint with a new state-of-the-art plant in the Midwest
